Last verified: April 2026

Kampavata — Parkinson-type Conditions

कम्पवात — Kampa (trembling) + Vata — Vata-caused trembling

Kampavata is the classical Ayurvedic condition most closely corresponding to Parkinson's disease — characterised by progressive Kampa (trembling/tremor), Stambha (rigidity), Chestasa Hrasa (reduction in voluntary movement), and Vakstambha (speech impairment). Charaka Samhita documents it as a Vata condition affecting the Majja Dhatu (nervous tissue) channels — and the primary classical herb, Kapikacchu, was later discovered to contain 3–6% L-DOPA, the dopamine precursor used as the primary conventional treatment for Parkinson's disease.

Important noticeThis page documents what classical Ayurvedic texts record. Not medical advice. Diagnosis and treatment require assessment by a qualified practitioner (BAMS or MD Ayurveda). Full disclaimer

Charaka Samhita, Chikitsasthana 28.53

Kampo vepathu stambhashcha chestasa hrasa eva cha / Vata nadi gata — Trembling (Kampa), shaking (Vepathu), rigidity (Stambha), and reduction of voluntary movement — these arise from Vata situated in the neural channels (Nadi). The treatment must nourish the neural channels and reduce the aggravated Vata within them.

Classical pathogenesis

Kampavata pathogenesis: Vata aggravation (from any cause — age, chronic disease, stress, improper diet) → Vata enters the Majja Vaha Srotas (marrow/nervous tissue channels) → Vata in the neural channels impairs the normal coordinated movement signals → Kampa (tremor at rest — the defining classical feature) develops. The progressive nature (Vata's movement quality spreading the condition through more channels over time), the rigidity (Vata's dryness producing channel stiffness), and the bradykinesia (Vata in excess eventually depletes the movement-initiating Prana) are all consistent with classical Vata-in-Majja pathology.

Kapikacchu — the primary herb

Kapikacchu (Mucuna pruriens) is documented in Charaka Samhita specifically for Vatavyadhi (Vata disorders) and Klaibya (neuromuscular conditions). The discovery that Mucuna pruriens seeds contain 3–6% L-DOPA (levodopa — the standard first-line Parkinson's pharmaceutical) provided a direct modern mechanism for the classical documentation. Clinical trials published in Journal of Neurology, Neurosurgery and Psychiatry (Katzenschlager et al., 2004) documented Mucuna pruriens seed powder producing similar L-DOPA bioavailability to conventional L-DOPA with potentially lower dyskinesia incidence. API Kapikacchu monograph: Part I, Vol IV.

Basti as primary Panchakarma

Basti (therapeutic enema) is the primary Panchakarma procedure for all Vata disorders including Kampavata — directly addressing the colon (Vata's primary seat) and through it the systemic Vata. Ashtanga Hridayam documents Matra Basti (small-volume oil enema) with Ashwagandha Ghrita or Bala Taila as specifically Neuroprotective in Vata-Majja conditions. The Karma Basti (30-session complete course) is the most comprehensive classical treatment approach for established Kampavata.